Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
Journal of Correctional Health Care · 2024
DOI: 10.1089/jchc.23.09.0079 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Correctional Health Care, 2024. Verfasst von Justina A Warnick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Aripiprazole, Schizophrenia, Treatment-Resistant. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
- Centurion Health, State Correctional Institution, Waymart, Pennsylvania, USA.
- University of Connecticut School of Medicine, Farmington, Connecticut, USA.
ORCID-Profile: Justina A Warnick
Zitieren
APA
Warnick, J. A., Gifeisman, R. I., Joshi, K. P., Roe, S. A., Hiciano, R. A., Conroy, C. P., & Zahedi, S. (2024). Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature. Journal of Correctional Health Care. https://doi.org/10.1089/jchc.23.09.0079
Vancouver
Warnick JA, Gifeisman RI, Joshi KP, Roe SA, Hiciano RA, Conroy CP, et al. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature. Journal of Correctional Health Care. 2024. doi:10.1089/jchc.23.09.0079
BibTeX
@article{Warnick2024,
author = {Warnick, Justina A and Gifeisman, Rachel I and Joshi, Khevna P and Roe, Sophie A and Hiciano, Rick A and Conroy, Christopher P and Zahedi, Sohrab},
title = {Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature},
journal = {Journal of Correctional Health Care},
year = {2024},
doi = {10.1089/jchc.23.09.0079}
}
EUVIMED